Healthcare Equipment and Supplies
Company Overview of NinePoint Medical, Inc.
NinePoint Medical, Inc., a transformational medical device company, develops medical devices for in vivo optical imaging. The company offers NvisionVLE Imaging System, an imaging tool that enables physicians and pathologists to view and evaluate real-time volumetric images of esophageal tissue microstructure below the surface by providing two-dimensional, cross-sectional, and real-time depth visualization. It delivers imaging information to support clinical decision-making relative to biopsy placement and treatment planning. NinePoint Medical, Inc. was incorporated in 2008 and is based in Bedford, Massachusetts.
12 Oak Park Drive
Bedford, MA 01730
Founded in 2008
Key Executives for NinePoint Medical, Inc.
Chief Executive Officer, President and Director
Senior Director of Manufacturing/Operations
Executive Vice President of Research and Development
Senior Director of Business Development and Strategic Planning
Compensation as of Fiscal Year 2016.
NinePoint Medical, Inc. Key Developments
NinePoint Medical, Inc. Presents at Redefining Early Stage Investments (RESI) Conference, Sep-13-2016
Sep 10 16
NinePoint Medical, Inc. Presents at Redefining Early Stage Investments (RESI) Conference, Sep-13-2016 . Venue: The Westin Copley Place, 10 Huntington Ave, Boston, MA 02116, United States.
NinePoint Medical, Inc. Announces FDA 510(k) Clearance of a Real-Time Targeting Feature for the NvisionVLE Imaging System
May 10 16
NinePoint Medical, Inc. announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market its Real-time Targeting feature for its product, the NvisionVLE Imaging System. In addition, the first procedures with this new system were performed at Beth Israel Deaconess Medical Center in Boston, Massachusetts. The NvisionVLE Imaging System employs proprietary Optical Coherence Tomography (OCT) technology allowing physicians to perform a Volumetric Laser Endomicroscopy (VLE) procedure that produces real-time, high-resolution cross-sectional images. This system enables gastroenterologists to evaluate tissue for potential disease that may not be visible with conventional medical imaging technologies such as endoscopy and ultrasound. The NvisionVLE Imaging System was launched in the U.S. in late 2013. To date, over 5,000 VLE procedures have been performed at hospitals in the U.S. The addition of this Real-time Targeting feature allows physicians to not only locate, but now to mark areas of interest. This marking feature, in combination with an improved workflow, enables more accurate targeting, potentially to improved diagnosis and more effective therapeutic treatment options for patients. The NvisionVLE Imaging System provides a unique and clinically valuable new perspective of esophageal disease: The ability to image within the wall of the esophagus. By providing a high-resolution, real-time scan of the esophagus using Optical Coherence Tomography (OCT) a technology similar to ultrasound but using infrared light rather than sound waves - the system enables physicians to view structures not evident with conventional imaging, and potentially identify disease that would have otherwise been missed. With the recent addition of a Real-time Targeting feature, physicians can not only locate, but now mark areas of interest. This marking feature, in combination with an improved workflow, enables more accurate targeting, potentially leading to improved diagnosis and more effective therapeutic decisions for patients. The NvisionVLE Imaging System has been cleared by the FDA and is commercially available in the U.S.
NinePoint Medical, Inc. Appoints John Temple as Vice President of Sales
May 3 16
NinePoint Medical, Inc. announced the appointment of John Temple as Vice President of Sales. Mr. Temple reports directly to the company’s President and CEO, Christopher R. von Jako, Ph.D. Mr. Temple joins the company with over 25 years of sales, management and leadership experience in the medical device business with both capital and single-use devices. His experiences span the continuum of medical device product development, from ideation to successful launches and sales execution. Prior to joining the company, Mr. Temple served as a key leader on the executive management team at Olympus America Inc. as Vice President of Sales for eight years. Over his 24-year career with Olympus, he held leadership roles of increasing responsibility within sales where he was responsible for the gastroenterology, pulmonary, surgical, digital integration, management information systems, and capsule endoscopy products. Earlier in his career, Mr. Temple worked at KARL STORZ Endoscopy-America, Inc. and Merrell Dow Pharmaceuticals, Inc.
Similar Private Companies By Industry
Recent Private Companies Transactions
November 12, 2015